Max Gu

Advised a leading on-demand cloud computing platforms and APIs provider on its data center construction and land use right/real estate transaction in China. 

Advises a U.S.-based gasification research institute on the construction of a demonstrative plant and joint venture project in China.

Advised a publicly traded China-based electric group in their CFIUS and HSR filings in the United States. 

Advised a publicly traded China-based port machinery company in its real estate and construction projects in Australia.   

Represented a U.S. aviation consulting company in their negotiation with airport authorities in China. 

Advised a U.S.-based company on their joint venture negotiation with SOEs in China in the industry to automobile.

Advised a U.S.-based company on their due diligence in relation to the acquisition of a hydropower plant in China.

Advised a number of U.S., UK and Australia-based food business operators in their business establishment and licensing issues in China.

Represented a U.S. sport brand in their merger and acquisition in China.

Represented a Hong Kong investment group in the establishment of their car dealerships of imported cars in China.

Represented a U.S. manufacturer of point-of-sales materials for brewery industry in their establishment of manufacturing facilities, litigation matters in China and offshore restructuring for financing purposes. 

Represented a U.S. data mining software developer to set up a wholly-owned subsidiary in China.

Served as senior in-house position in China for a world-leading diversified healthcare and nutrition foods company with primary responsibilities over all aspects of the company’s business operations in China.   

Provided due diligence for a medical device company regarding acquiring a Beijing medical device company.

Represented a China-based new construction materials company which seeks to go public in Hong Kong.

Represent a China-based real estate company which seeks to go public in Hong Kong.

Represented a China-based aesthetical medicine company which seeks to go public in Hong Kong.

Represented a China-based e-commerce provider which seeks to go public in the United States.

Represent a China-based canned fruit manufacturer which seeks to go public in the United States.

Represented a China-based marketing solution company and a China-based automobile equipment manufacturer which sought to go public in Hong Kong.

Represented a U.S.-based public company in the specialty chemicals industry in its FCPA and environment violation (involving criminal liability) investigation in Jiangsu Province, China.

Represented a number of U.S./Europe/Australia-based companies in their adversarial employment-related proceedings in China, which had an official or commercial bribery element as the cause for termination. 

Represent a publicly traded China-based port machinery company in litigations and regulatory compliance matters in the United States.

Represented a publicly traded Chinese construction equipment company to set up assembly facilities in the United States.

Represented a U.S. supplier of Wal-Mart in sourcing products and intellectual property litigation matters in China.